AstraZeneca

PatientsLikeMe and M2Gen Announce Partnership and Plans for Landmark Cancer Experience Study

  CAMBRIDGE, Mass. & TAMPA, Fla., March 8, 2016—Patient network PatientsLikeMe® and informatics solutions provider M2Gen® are collaborating to give patients and researchers a more complete picture of patients’ experiences with cancer treatments and to shed new light on the factors that may affect outcomes and quality of life. The partnership aims to advance cancer

PatientsLikeMe and M2Gen Announce Partnership and Plans for Landmark Cancer Experience Study Read More »

The American College of Cardiology and PatientsLikeMe to Bring Patient Focus to Diabetes Research and Care

Real-world, clinical insights and patient engagement central to improving health outcomes  WASHINGTON and CAMBRIDGE, MASS., November 9, 2015—The American College of Cardiology (ACC) and PatientsLikeMe have launched a partnership to explore innovative ways to make real-world patient feedback and experience more central to diabetes research and care. Focused on the ACC’s Diabetes Collaborative Registry®, the partnership

The American College of Cardiology and PatientsLikeMe to Bring Patient Focus to Diabetes Research and Care Read More »

Bruce Cooper and Ed Godber talk about the AstraZeneca/PatientsLikeMe partnership

AstraZeneca and PatientsLikeMe announced today that they’re working together to use patient-reported data to shape future medicines and help improve patient outcomes. While it focuses on an initial set of four therapeutic areas (lupus, respiratory diseases, oncology and diabetes) the partnership signals a significant step forward for patients worldwide. Bruce Cooper, AstraZeneca’s Senior Vice President,

Bruce Cooper and Ed Godber talk about the AstraZeneca/PatientsLikeMe partnership Read More »

PatientsLikeMe and AstraZeneca announce global research collaboration

           Five-year agreement focused on improving health outcomes for patients across main therapy areas CAMBRIDGE, MA, April 13, 2015—In a major step forward to make patient-centric evidence a cornerstone of scientific discovery and development, PatientsLikeMe and AstraZeneca (NYSE: AZN) have signed a five-year agreement to provide access to PatientsLikeMe’s global network

PatientsLikeMe and AstraZeneca announce global research collaboration Read More »

Scroll to Top